ARTEMISMED Artemis Medicare Services Q3 FY26 results (Oct–Dec 2025) and concall
Artemis Medicare delivered a strong Q3 FY26 performance with robust revenue and PAT growth, driven by core specialties and international patient volumes. The company is actively pursuing significant capacity expansions, including the imminent commissioning of the Raipur hospital and plans for a large South Delhi facility, supported by a recently approved INR 700 crores fundraise. Management is focused on operational efficiencies and optimizing payer mix, despite some current cost pressures from new projects.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 17.2%, net profit up 4.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 241 | 232 | 240 | 255 | 275 +14% | 272 +17% |
| EBITDA | 42 | 37 | 36 | 41 | 51 +21% | 45 +22% |
| Net profit | 22 | 21 | 23 | 21 | 30 +36% | 22 +5% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
